| Literature DB >> 34557566 |
Khanh Pham1, Lee Gottesdiener1, Matthew S Simon1,2, Alex Trzebucki1, Grace A Maldarelli1, Babacar Cisse1,3, Joshua Lieberman4, Elliot DeHaan1,2, David Pisapia1,5.
Abstract
We present a case of a human immunodeficiency virus-negative man with syphilitic meningovascular disease with subjacent involvement of brain parenchyma leading to a mass-forming inflammatory lesion that was pathologically distinct from a typical gumma. Syphilis was diagnosed after tissue obtained from a brain biopsy demonstrated spirochetes consistent with Treponema pallidum and confirmed by 16S ribosomal RNA sequencing.Entities:
Keywords: PCR; incipient gumma; meningovascular syphilis
Year: 2021 PMID: 34557566 PMCID: PMC8454516 DOI: 10.1093/ofid/ofab455
Source DB: PubMed Journal: Open Forum Infect Dis ISSN: 2328-8957 Impact factor: 3.835
Figure 1.Preoperative brain magnetic resonance imaging. Preoperative axial T1 sequence with contrast. Abbreviations: AXL, axial; AFL, anterior/foot/left; FLAIR +C, fluid-attenuated inversion recovery with contrast; LH, left/head; PHR, posterior/head/right; RF, right/foot.
Figure 2.Pathology of tissue obtained from craniotomy. A, Hematoxylin and eosin staining demonstrates a mixed lymphoplasmacytic infiltrate involving the leptomeninges and Virchow-Robin spaces. Scale bar: 100 μm. B, Diffuse parenchymal involvement and effacement of the underlying cerebral cortical architecture. Scale bar: 50 μm. C, Immunohistochemical staining for CD138 highlights the extensive plasma cell involvement typical of syphilitic inflammatory lesions. Scale bar: 100 μm. D, Immunohistochemical staining against treponemal antigen shows numerous corkscrew-shaped organisms. Scale bar: 20 μm.
Figure 3.Postoperative brain magnetic resonance imaging. Postoperative (6-month follow-up) axial T1 sequence with contrast. Abbreviations: Ax, axial; AFR, anterior/foot/right; LHA, left/head/anterior; PHL, posterior/head/left; RFP, right/foot/posterior; TSE, turbo spin echo.
Literature Review of Reported Cerebral Syphilitic Masses in the Last 10 Years With Pertinent Features of Demographics and Diagnostics Reported
| First Author | Year | Age/Sex | Country | Known HIV Status | CSF Treponemal Test | CSF Nontreponemal Test | PCR Test | Surgery or Biopsy |
|---|---|---|---|---|---|---|---|---|
| Ventura [ | 2012 | 26/M | Brazil | Yes | NR | NR | NR | No |
| Dhasmana [ | 2013 | 40/M | UK | No | Pos (TPPA) | Pos (VDRL) | NR | Yes |
| Yoon [ | 2013 | 59/F | South Korea | No | Pos (FTA-ABS) | Neg (VDRL) | Neg | Yes |
| Sprenger [ | 2014 | 40/M | Switzerland | Yes | Neg (TPHA) | NR | NR | Yes |
| Hamauchi [ | 2014 | 23/F | Japan | No | Pos (TPHA) | NR | NR | No |
| Faropoulos [ | 2016 | 53/M | Greece | No | NR | NR | NR | Yes |
| Tsuboi [ | 2016 | 21/M | Japan | Yes | Pos (FTA-ABS) | Pos (TPHA) Neg (RPR) | NR | No |
| Zhang [ | 2017 | 56/M | China | No | Pos (TPPA) | Neg (RPR) | Pos (polA) | Yes |
| Xia [ | 2017 | 62/M | China | No | Pos (TPPA) | Pos (RPR) | NR | Yes |
| Murakawa [ | 2017 | 24/M | Japan | No | Pos (TPPA) | Pos (RPR) | NR | No |
| Shi [ | 2017 | 41/M | China | No | NR | Neg (RPR, VDRL) | NR | No |
| Kuroi [ | 2018 | 62/M | Japan | No | NR | Pos (RPR) | NR | Yes |
| Shao [ | 2018 | 62/M | China | No | Pos (TPPA) | Neg (RPR) | NR | Yes |
| Shao [ | 2018 | 66/M | China | No | Pos (TPPA) | Pos (RPR) | NR | Yes |
| Shao [ | 2018 | 37/M | China | No | Pos (TPPA) | Pos (RPR) | NR | No |
| Ying [ | 2018 | 52/F | China | No | Pos (TPPA) | Pos (RPR) | NR | Yes |
| Koizumi [ | 2018 | 44/M | Japan | Yes | Neg (TPLA) | Neg (RPR) | Pos (polA, TpN47) | Yes |
| Kodama [ | 2018 | 36/M | Japan | No | Pos (TPLA) | Pos (RPR) | NR | No |
| Weng [ | 2019 | 45/M | China | No | Pos (TPPA) | Pos (TRUST) | NR | Yes |
| Sasaki [ | 2019 | 47/M | Japan | No | Pos (FTA-ABS, TPHA) | NR | NR | No |
| Shen [ | 2019 | 22/M | China | No | NR | Pos (TRUST) | NR | No |
| Cui [ | 2020 | 52/F | China | No | NR | NR | NR | Yes |
| Xia [ | 2020 | 49/F | China | No | NR | NR | NR | Yes |
| Thibodeau [ | 2021 | 37/F | USA | No | NR | NR | NR | Yes |
| Yu [ | 2021 | 54/M | China | No | NR | NR | NR | Yes |
| This report | 2021 | 25/M | USA | No | Neg (FTA-ABS) | Neg (VDRL) | Pos (16S rRNA) | Yes |
Abbreviations: CSF, cerebrospinal fluid; F, female; FTA-ABS, fluorescent treponemal antibody absorption; HIV, human immunodeficiency virus; M, male; Neg, negative; NR, not reported; PCR, polymerase chain reaction; poIA, gene coding for DNA polymerase I; Pos, positive; RPR, rapid plasma reagin; rRNA, ribosomal RNA; TPHA, Treponema pallidum hemagglutination assay; TPLA, Treponema pallidum latex agglutination; TpN47, recombinant protein; TPPA, Treponema pallidum particle agglutination; TRUST, toluidine red unheated serum test; UK, United Kingdom; USA, United States; VDRL, Venereal Disease Research Laboratory.